These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18420083)

  • 1. [Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
    Hajlaoui K; Zeglaoui F; Ezzine N; Kastalli S; Elfekih N; Fazaa B; Loueslati MH; Kamoun MR
    Ann Dermatol Venereol; 2008 Apr; 135(4):317-8. PubMed ID: 18420083
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis.
    Rodrigues ML; Costa RS; Souza CS; Foss NT; Roselino AM
    Rev Inst Med Trop Sao Paulo; 1999; 41(1):33-7. PubMed ID: 10436668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous leishmaniasis in travelers 2009.
    Blum JA; Hatz CF
    J Travel Med; 2009; 16(2):123-31. PubMed ID: 19335813
    [No Abstract]   [Full Text] [Related]  

  • 6. Back from the Peace Corps--with skin lesions from South America.
    Sorci JJ; Cordova X; Usatine RP
    J Fam Pract; 2003 Jul; 52(7):531-6. PubMed ID: 12884834
    [No Abstract]   [Full Text] [Related]  

  • 7. American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.
    de Camargo Ferreira E Vasconcellos E; de Oliveira Schubach A; Valete-Rosalino CM; de Souza Coutinho R; Conceição-Silva F; de Matos Salgueiro M; Rosandiski Lyra M; Soares Moreira J; Azeredo-Coutinho RB; Fernandes Pimentel MI; Roberto Mortari S; de Fátima Madeira M; Pereira Quintella L; Baptista C; de Almeida Marzochi MC
    J Am Geriatr Soc; 2010 Mar; 58(3):614-6. PubMed ID: 20398135
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.
    Rashid BN; Tabassum S; Ullah Rao MS; Masood S; Abbas MM; Mumtaz MJ
    J Coll Physicians Surg Pak; 2010 Jul; 20(7):496. PubMed ID: 20642959
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
    Neves DB; Caldas ED; Sampaio RN
    Trop Med Int Health; 2009 Dec; 14(12):1515-22. PubMed ID: 19954451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R; Handjani F; Nouhpisheh MK
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical follow-up examination after treatment of canine leishmaniasis.
    Moritz A; Steuber S; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous leishmaniasis and multidermatomic herpes zoster].
    Arboleda M; Jaramillo L; Ortiz D; Díaz A
    Rev Chilena Infectol; 2013 Dec; 30(6):680-2. PubMed ID: 24522317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia].
    Mlika BR; El Aïdli S; Ben Brahim M; Badri T; Chouk S; Ben Jannet S; Marrrak H; Daghfous R; Mokhtar I; Fenniche S
    Med Trop (Mars); 2008 Oct; 68(5):499-501. PubMed ID: 19068983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug hypersensitivity syndrome induced by meglumine antimoniate.
    Jeddi F; Caumes E; Thellier M; Jauréguiberry S; Mazier D; Buffet PA
    Am J Trop Med Hyg; 2009 Jun; 80(6):939-40. PubMed ID: 19478253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.